Teva offers EU concessions over Allergan generics deal - EU

BRUSSELS (Reuters) - Teva Pharmaceutical Industries Ltd has offered concessions to allay antitrust concerns over its $40.5 billion bid for Allergan's generics unit, European Union regulators said on Friday.

http://ift.tt/1mLGwOO

from Reuters: Health News
via animenewspro